Schonfeld Strategic Advisors’s Pfizer PFE Stock Holding History

Schonfeld Strategic Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-150,000	Closed	-$3.73M	–	2564
2025 Q4	$3.73M	Buy	150,000 +1,000	+0.7%	+$25.2K	0.02%	648
2025 Q3	$3.8M	Buy	+149,000	New	+$3.68M	0.02%	719
2025 Q2	–	Sell	-1,082,500	Closed	-$27.4M	–	2417
2025 Q1	$27.4M	Buy	+1,082,500	New	+$28.3M	0.17%	101
2024 Q4	–	Sell	-300,000	Closed	-$8.68M	–	2294
2024 Q3	$8.68M	Sell	300,000 -850,000	-74%	-$24.8M	0.06%	336
2024 Q2	$32.2M	Buy	1,150,000 +1,000,000	+667%	+$27.5M	0.21%	86
2024 Q1	$4.16M	Buy	+150,000	New	+$4.16M	0.03%	719
2023 Q4	–	Sell	-150,000	Closed	-$4.98M	–	2142
2023 Q3	$4.98M	Sell	150,000 -150,000	-50%	-$5.3M	0.04%	552
2023 Q2	$297K	Buy	+300,000	New	+$11.7M	﹤0.01%	1400

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Schonfeld Strategic Advisors's PFE Position: Q4 2025 in Review

Schonfeld Strategic Advisors sold out of Pfizer (PFE) in Q4 2025, closing a stake of 501,279 shares — an estimated $12.6M sold.

Schonfeld Strategic Advisors first reported a position in PFE in Q1 2016 and held it in 29 quarters. The position peaked at $39.6M in Q1 2024. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

Schonfeld Strategic Advisors reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
Schonfeld Strategic Advisors sold 501,279 Pfizer shares in Q4 2025, an estimated $12.6M.
Schonfeld Strategic Advisors first reported a position in Pfizer in Q1 2016 and held it in 29 quarters.
Schonfeld Strategic Advisors's Pfizer position peaked at $39.6M in Q1 2024.
2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.